Hyaluronidase (ovine) clinical trials
Also written Vitrase and ovine hyaluronidase.
How each study uses hyaluronidase (ovine) is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2004 (4)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 1999 | 1 |
| 2004 | 4 |
| 2005 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Studies
Open first, then newest update. How each study uses hyaluronidase (ovine) is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected AnestheticsCompletedPhase 4Bausch & Lomb IncorporatedNCT00198549Written as Vitrase (ovine hyaluronidase) Lyophilized
- Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)CompletedPhase 1Bausch & Lomb IncorporatedNCT00198458Written as Vitrase
- Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous HemorrhageCompletedPhase 3Bausch & Lomb IncorporatedNCT00198510Written as Vitrase
- Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous DetachmentCompletedPhase 2Bausch & Lomb IncorporatedNCT00198471Written as Vitrase
- Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous HemorrhageCompletedPhase 3Bausch & Lomb IncorporatedNCT00198497Written as Vitrase
- Evaluation of Vitrase as a Spreading AgentCompletedPhase 3Bausch & Lomb IncorporatedNCT00198484Written as Vitrase
- Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)CompletedPhase 1Bausch & Lomb IncorporatedNCT00198419Written as Vitrase
Codes
What other systems call hyaluronidase (ovine) · ClinicalTrials.gg INT015192
- UNII (FDA) 64R4OHP8T0HYALURONIDASE (OVINE)One source FDA
- RxNorm 486164One source FDA
- NCI Thesaurus C65861Hyaluronidase, OvineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 64R4OHP8T0 | HYALURONIDASE (OVINE) | One source FDA |
| RxNorm | 486164 | — | One source FDA |
| NCI Thesaurus | C65861 | Hyaluronidase, Ovine | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.